Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

The Dollar’s Ripping Higher: Cash In With These 3 Under-the-Radar Plays

By Josh Enomoto, InvestorPlace Contributor

With the dollar rising above a basket of international currencies, these under-the-radar stocks may benefit handsomely.

CGC Stock Alert: Canopy Growth Gets Green Light for Canopy USA

By Josh Enomoto, InvestorPlace Contributor

Although Canopy Growth shareholders approved a proposition to create a U.S.-focused entity, dilution risks clouded CGC stock.

Jobs Boom Means Big Gains: 3 Consumer Cyclical Stocks to Buy as Employment Surges

By Josh Enomoto, InvestorPlace Contributor

Last month, the economy added 303,000 nonfarm payrolls, potentially translating to a swing higher in consumer cyclical stocks. More dollars are chasing after fewer goods.…

7 Energy Stocks Poised to Profit as Crude Oil Prices Soar

By Josh Enomoto, InvestorPlace Contributor

Crude oil prices show little sign of slowing their ascent (and probably won’t), meaning it’s a great time to consider energy stocks. Yeah, it may…

Biotech on a Budget: 7 Stocks Under $10 With Huge Potential

By Josh Enomoto, InvestorPlace Contributor

The broader medical therapeutic sector is already volatile so it stands to reason in some sense to consider under-$10 biotech stocks. Imagine you acquired shares…

Load More